New Approvals, Biosecurity In Spotlight As China Gears For National Congress
Proposed Law Gains Momentum Post-COVID-19
Executive Summary
China grants new approvals to multiple new drugs for cancer and rare diseases, as the government gears up to hold its delayed annual congress in Beijing, attended by thousands of delegates who will vote on key new biosecurity legislation as the pandemic appears to be receding in the country.